NOOTROPIC PEPTIDES

Selank

A synthetic heptapeptide analogue of tuftsin, supplied in 10mg vials with independent batch analysis and Australian dispatch.

About Selank

Selank is a synthetic heptapeptide derived from tuftsin, a naturally occurring immunomodulatory tetrapeptide, with a stabilising sequence appended to extend its half-life. It was developed at the Institute of Molecular Genetics in Russia and most of the published literature on it originates there.

It is frequently studied alongside Semax, another Russian-developed research peptide, which is why we also stock a bundle containing both. Selank has no marketing approval in Australia and is not a registered medicine here.

Researcher pipetting into a sample tube

Nootropic Research Range

Selank 10mg

Lyophilised powder in a sealed vial, released against an independent HPLC certificate.

Semax 10mg

A heptapeptide derived from the ACTH(4-10) fragment, commonly studied alongside Selank.

Nootropic Bundle

Both vials supplied together for research groups running the two compounds in parallel.

Explore the nootropic range

Research Use Only. Not registered on the Australian Register of Therapeutic Goods. Not a medicine and not supplied for human or veterinary use. Nothing on this page is medical advice or a therapeutic claim. Purchasers must be 18 years or older and qualified to handle research chemicals.